Crizotinib‐induced anti‐cancer activity in human cervical carcinoma cells via ROS ‐dependent mitochondrial depolarization and induction of apoptotic pathway-Reference-Cited by-同舟云学术

Crizotinib‐induced anti‐cancer activity in human cervical carcinoma cells via ROS ‐dependent mitochondrial depolarization and induction of apoptotic pathway

Published:2021-09-05 Issue:11 Volume:47 Page:3923-3930
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Varma Diksha A.¹,Tiwari Manisha¹^ORCID

Affiliation:

1. Dr. B. R Ambedkar Centre for Biomedical Research University of Delhi, North Campus New Delhi India

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.15003

Reference25 articles.

1. Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

2. An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

3. Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond

4. The potential for crizotinib in non-small cell lung cancer: a perspective review

5. FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phosphoramidate Prodrug Platform: One‐Pot Amine Functionalization of Kinase Inhibitors with Oligoethylene Glycol for Improved Water‐Solubility;Chemistry – A European Journal;2024-08-12

2. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer;Cancer Cell International;2024-07-09

3. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3;Phytomedicine;2024-06

4. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer;Frontiers in Genetics;2022-12-06